| NASDAQ (usa) |   | 6715.56 | -12.11 | -0.18% | 
| FTSE 100 (london) |  | 7487.96 | -5.12 | -0.07% | 
| DAX (german) |   | 13465.51 | 235.94 | 1.78% | 
| NIKKEI 225 (japan) |   | 22420.08 | 408.47 | 1.86% | 
| Hang - Seng (hong kong) |   | 28594.06 | 348.52 | 1.23% | 
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |   | 3391.61 | 17.53 | 0.52% | 
| KOSPI (korea) |   | 2556.47 | 33.04 | 1.31% | 
| All Ordinaries (australia) |   | 6005.30 | 28.90 | 0.48% | 
| BOVESPA (brazil) |   | 74092.76 | -215.73 | -0.29% | 
Harvard Bioscience Inc (NASDAQ: HBIO)
                                    	HBIO Technical Analysis
                                    
                                    
    5
    
    
    
    
									| As on 30th Oct 2025 HBIO STOCK Price closed @ 0.63 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.21 & Strong Sell for SHORT-TERM with Stoploss of 3.09 we also expect STOCK to react on Following IMPORTANT LEVELS. | 
HBIOSTOCK Price
| Open | 0.57 | Change | Price | % | 
| High | 0.94 | 1 Day | 0.18 | 40.00 | 
| Low | 0.52 | 1 Week | 0.22 | 53.66 | 
| Close | 0.63 | 1 Month | 0.15 | 31.25 | 
| Volume | 315514539 | 1 Year | -2.82 | -81.74 | 
| 52 Week High 3.54 | 52 Week Low 0.28 | ||||
    NASDAQ USA Most Active Stocks
                    | AMRS | 0.14 | 100.00% | 
| WBA | 11.98 | 0.50% | 
| HBIO | 0.63 | 40.00% | 
| CMBM | 3.75 | 27.12% | 
| NVDA | 202.89 | -2.00% | 
| BYND | 1.65 | -10.33% | 
| ONDS | 6.29 | -6.81% | 
| LMDX | 0.02 | 0.00% | 
| OPEN | 7.34 | -4.05% | 
| AKTS | 0.04 | 0.00% | 
NASDAQ USA Top Gainers Stocks
                    
                NASDAQ USA Top Losers Stocks
                    
                | HBIO Daily Charts | HBIO Intraday Charts | Whats New @ Bazaartrend | HBIO Free Analysis | 
|  | 
HBIO Important Levels Intraday
                                    | RESISTANCE | 1.44 | 
| RESISTANCE | 1.18 | 
| RESISTANCE | 1.02 | 
| RESISTANCE | 0.86 | 
| SUPPORT | 0.40 | 
| SUPPORT | 0.24 | 
| SUPPORT | 0.08 | 
| SUPPORT | -0.18 | 
HBIO Forecast  October 2025
                                    | 4th UP Forecast | 2.36 | 
| 3rd UP Forecast | 1.81 | 
| 2nd UP Forecast | 1.46 | 
| 1st UP Forecast | 1.12 | 
| 1st DOWN Forecast | 0.14 | 
| 2nd DOWN Forecast | -0.2 | 
| 3rd DOWN Forecast | -0.55 | 
| 4th DOWN Forecast | -1.1 | 
     HBIO Weekly Forecast
                                    
                                    
                                | 4th UP Forecast | 1.34 | 
| 3rd UP Forecast | 1.11 | 
| 2nd UP Forecast | 0.97 | 
| 1st UP Forecast | 0.83 | 
| 1st DOWN Forecast | 0.43 | 
| 2nd DOWN Forecast | 0.29 | 
| 3rd DOWN Forecast | 0.15 | 
| 4th DOWN Forecast | -0.08 | 
HBIO Forecast2025
                                    | 4th UP Forecast | 7.03 | 
| 3rd UP Forecast | 4.98 | 
| 2nd UP Forecast | 3.71 | 
| 1st UP Forecast | 2.44 | 
| 1st DOWN Forecast | -1.18 | 
| 2nd DOWN Forecast | -2.45 | 
| 3rd DOWN Forecast | -3.72 | 
| 4th DOWN Forecast | -5.77 | 
                                        Harvard Bioscience Inc ( NASDAQ USA Symbol : HBIO ) 
Sector : Healthcare And Other Stocks in Same Sector
                                    
                                    
                                Sector : Healthcare And Other Stocks in Same Sector
HBIO Other Details
                    | Segment | EQ | |
| Market Capital | 294715776.00 | |
| Sector | Healthcare | |
| Industry | Medical Instruments & Supplies | |
| Offical website | > echo $website ; ?> | |
HBIO Address
                                 |  | ||
                                        HBIO Latest News
                                    
                                    
                                    HBIO Business Profile
   
	 Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, China, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts. Address: 84 October Hill Road, Holliston, MA, United States, 01746 
	
            
            © 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
 
	   Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

